WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 544  539  535  530  525  467  407  366 
Births 10  10  10  10  10  11  10  11 
Surviving infants 10  11 
Pop. less than 5 years 47  47  46  47  48  50  47  46 
Pop. less than 15 years 146  148  149  149  150  143  136  146 
Female 15-49 years 141  140  140  139  137  123  104  87 

Number of reported case

(Click for retrospective incidence data for Suriname)
Diphtheria
Japanese encephalitis
Measles 35  254 
Mumps
Pertussis 13 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 40  11 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Suriname)
Vaccine year result method % card seen                                                
BCG         
DTP1 2005  96  MICS   81  91  91  80  90  99 
DTP3 2005  91  MICS   81  85  87  84  86  96  71  83  25 
DTP4          64 
IPV1         
HepB_BD          64  45  84 
HepB3 2005  MICS   81  85  86  84  86  86 
Hib3 2005  MICS   81  85  86  84  86  86 
JapEnc         
MCV1          85  93  73  85  90  71  65 
MCV2          18  18 
PCV1         
PCV3         
Pol3 2009  83  MICS   82  85  87  84  86  96  70  81  24 
Rota1         
Rota_last         
Rubella1          85  93  73  85  99 
TT2plus 2009  27  MICS   82  76  30 
PAB         
VAD1         
YFV 2009  64  MICS   82  79  93  73  81  80 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Suriname)
DTP1 91  91  94  90  99  90  94  50 
DTP3 85  86  84  86  96  71  83  25 
HepB3 85  86  84  86  86 
HepB_BD 64  45  51  46  41 
Hib3 85  86  84  86  86 
MCV1 85  93  73  85  90  84  65 
MCV2 18  18 
PAB 93  93  93  93  93  92  92 
PCV3
Pol3 85  86  84  86  96  70  81  24 
Rota_last
YFV 79  76  73  10  11 

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 40
From 80 to 89% 40
From 50 to 79% 20
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT > 5 years; Yes booster
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9 years; Yes
HepB_Adult st contact; +1, +6 months; Yes
HepB_Pediatric birth; Yes
IPV Yes From October 2015
Influenza_Adult adults with chronic diseases, pregnant women and health care workers
MMR 1, 4 years; Yes
MenACWY 1st contact; Yes travelers
OPV 2, 4, 6, 18 months; 4 years; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes pregnant women
Tdap No 3rd trimester of pregnancy
YF 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  Yes  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number     10 

System performance

Total Nº districts in country number 10  10  10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 80  80  90  90  80 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 20  50    20  40  10 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 98    100  97  84  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.